Profile
Raymund Scheffrahn worked as an Executive Director at Goldman Sachs International.
He also worked as a Principal at Novartis International AG and as a Principal at Credit Suisse First Boston Merchant Bank, Inc. Scheffrahn was the Chief Financial Officer at agta record AG and at Glaxosmithkline Consumer Healthcare UK No.1 Ltd.
He was also the Managing Director & Chief Financial Officer at Athris AG.
Scheffrahn received his undergraduate and doctorate degrees from the University of Zurich.
Former positions of Raymund Scheffrahn
Companies | Position | End |
---|---|---|
ATHRIS HOLDING AG | Chief Executive Officer | 2010-12-31 |
Glaxosmithkline Consumer Healthcare UK No.1 Ltd.
Glaxosmithkline Consumer Healthcare UK No.1 Ltd. Pharmaceuticals: MajorHealth Technology Glaxosmithkline Consumer Healthcare UK No.1 Ltd. manufactures pharmaceutical products. The company was founded on March 13, 1963 and is headquartered in Camberley, the United Kingdom. | Director of Finance/CFO | 2007-12-31 |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 2005-12-31 |
Credit Suisse First Boston Merchant Bank, Inc. | Corporate Officer/Principal | 2000-12-31 |
AGTA RECORD LTD | Director of Finance/CFO | - |
Training of Raymund Scheffrahn
University of Zurich | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ATHRIS HOLDING AG | Finance |
Private companies | 5 |
---|---|
Goldman Sachs International
Goldman Sachs International Financial ConglomeratesFinance Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals. | Finance |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
agta record AG
agta record AG Miscellaneous ManufacturingProducer Manufacturing agta record AG engages in the design, manufacture, maintenance, and installation of automatic pedestrian doors. It operates through the Europe and Rest of World and North America geographical segments. The Europe and Rest of World segment includes all European countries, China, and all other countries served through its Switzerland based export operation. The North America segment consists of the United States and Canada. The company’s products include automatic sliding doors and its devices; linear, telescopic, folding, swing and revolving doors; escape route systems; sealing, hygienic and burglar-resistant doors; smoke and fire-resistant sliding doors, curved and round sliding doors, high-speed gates for industrial applications, and one-way security access systems. agta record was founded by Helmut Heinz Bunzl in 1953 and is headquartered in Fehraltorf, Switzerland. | Producer Manufacturing |
Credit Suisse First Boston Merchant Bank, Inc. | |
Glaxosmithkline Consumer Healthcare UK No.1 Ltd.
Glaxosmithkline Consumer Healthcare UK No.1 Ltd. Pharmaceuticals: MajorHealth Technology Glaxosmithkline Consumer Healthcare UK No.1 Ltd. manufactures pharmaceutical products. The company was founded on March 13, 1963 and is headquartered in Camberley, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Raymund Scheffrahn